logo-loader

Kazia Therapeutics Ltd

Receive alerts
Market:
ASX
Market Cap:
$27.35 m
Price
0.44 AUD
Change
3.53%
52 weeks high
0.60
52 weeks low
0.32

In brief

Kazia Therapeutics (ASX: KZA, NASDAQ: KZIA) pipeline includes two clinical-stage drug development candidates.

Deep dive We explore the investor case for growth companies

Snapshot

  • A young biotech with brain cancer and ovarian cancer therapeutics in its pipeline. 
  • The company's early-stage research with initial results from a brain cancer trial are expected in December quarter. 
  • Its pipeline offers hope to patients and clinicians in difficult to treat cancers.